ABVX
Price
$7.65
Change
+$0.25 (+3.38%)
Updated
Jun 30 closing price
Capitalization
465.51M
41 days until earnings call
XENE
Price
$31.30
Change
-$1.10 (-3.40%)
Updated
Jun 30 closing price
Capitalization
2.4B
37 days until earnings call
Interact to see
Advertisement

ABVX vs XENE

Header iconABVX vs XENE Comparison
Open Charts ABVX vs XENEBanner chart's image
Abivax SA
Price$7.65
Change+$0.25 (+3.38%)
Volume$487.21K
Capitalization465.51M
Xenon Pharmaceuticals
Price$31.30
Change-$1.10 (-3.40%)
Volume$1.07M
Capitalization2.4B
ABVX vs XENE Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. XENE commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and XENE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (ABVX: $7.65 vs. XENE: $31.30)
Brand notoriety: ABVX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 224% vs. XENE: 76%
Market capitalization -- ABVX: $465.51M vs. XENE: $2.4B
ABVX [@Biotechnology] is valued at $465.51M. XENE’s [@Biotechnology] market capitalization is $2.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 4 TA indicator(s) are bullish while XENE’s TA Score has 3 bullish TA indicator(s).

  • ABVX’s TA Score: 4 bullish, 6 bearish.
  • XENE’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, XENE is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +25.20% price change this week, while XENE (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

ABVX is expected to report earnings on Aug 11, 2025.

XENE is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($2.4B) has a higher market cap than ABVX($466M). ABVX YTD gains are higher at: 4.508 vs. XENE (-20.153). ABVX has higher annual earnings (EBITDA): -170.04M vs. XENE (-290.36M). XENE has more cash in the bank: 550M vs. ABVX (104M). XENE has less debt than ABVX: XENE (8.68M) vs ABVX (92.6M). XENE has higher revenues than ABVX: XENE (7.5M) vs ABVX (0).
ABVXXENEABVX / XENE
Capitalization466M2.4B19%
EBITDA-170.04M-290.36M59%
Gain YTD4.508-20.153-22%
P/E RatioN/AN/A-
Revenue07.5M-
Total Cash104M550M19%
Total Debt92.6M8.68M1,067%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXXENE
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 15 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVRX14.14N/A
N/A
Hartford International Equity R3
BMGCX27.84N/A
N/A
BlackRock Mid-Cap Growth Equity Inv C
JMVAX15.62N/A
N/A
Janus Henderson Mid Cap Value I
PWTYX52.15N/A
N/A
UBS US Allocation P
PBSRX13.90N/A
N/A
Polen US Small Company Growth Investor

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with SYRE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+3.38%
SYRE - ABVX
38%
Loosely correlated
-1.64%
CGON - ABVX
38%
Loosely correlated
+0.19%
XENE - ABVX
38%
Loosely correlated
-3.40%
MLTX - ABVX
35%
Loosely correlated
-0.67%
DYN - ABVX
35%
Loosely correlated
-0.52%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with IDYA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
-3.40%
IDYA - XENE
55%
Loosely correlated
-1.64%
CRNX - XENE
54%
Loosely correlated
-4.01%
ATXS - XENE
53%
Loosely correlated
-1.47%
NRIX - XENE
51%
Loosely correlated
-2.15%
KYMR - XENE
50%
Loosely correlated
-1.09%
More